Cargando…

Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation

BACKGROUND: ISR remains the major adverse outcome after percutaneous coronary intervention (PCI). MicroRNAs have been demonstrated to be associated with coronary plaque and stable in the blood and can be used as biomarkers/predictors. This study aimed to investigate whether circulating microRNAs cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yuan, Liu, Xiaoxian, Hao, Shengyun, He, Qian, Shen, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333105/ https://www.ncbi.nlm.nih.gov/pubmed/32647681 http://dx.doi.org/10.21037/atm-20-4227

Ejemplares similares

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019)

Independent and combined effects of environmental factors and miR-126, miR-143, and miR-145 on the risk of coronary heart disease
por: Lin, Da–Cen, et al.
Publicado: (2017)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
por: Wang, Jing, et al.
Publicado: (2021)

The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles
por: Almeida, Maria Inês, et al.
Publicado: (2016)

miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions
por: Cordes, Kimberly R., et al.
Publicado: (2009)

rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk
por: Hall, Ignacio Fernando, et al.
Publicado: (2021)

MiR-93-5p is a novel predictor of coronary in-stent restenosis
por: O'Sullivan, John F, et al.
Publicado: (2019)

Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia
por: Liu, Kejian, et al.
Publicado: (2017)

MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer
por: Su, Jiaojiao, et al.
Publicado: (2014)

Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines
por: Koo, Sunwoo, et al.
Publicado: (2012)

miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
por: Lei, Chao, et al.
Publicado: (2017)

miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis
por: Gutierrez-Carretero, Encarnación, et al.
Publicado: (2021)

MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer
por: Meng, Wen-Jian, et al.
Publicado: (2015)

miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
por: Yan, Xin, et al.
Publicado: (2014)

Loss of miR-143 and miR-145 in condyloma acuminatum promotes cellular proliferation and inhibits apoptosis by targeting NRAS
por: Liu, Xiaoyan, et al.
Publicado: (2018)

miR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation
por: Anton, Lauren, et al.
Publicado: (2017)

Regulation of intraocular pressure by microRNA cluster miR-143/145
por: Li, Xinyu, et al.
Publicado: (2017)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Lessons from miR-143/145: the importance of cell-type localization of miRNAs
por: Kent, Oliver A., et al.
Publicado: (2014)

Analysis of association of potentially functional genetic variants within genes encoding miR-34b/c, miR-378 and miR-143/145 with prostate cancer in Serbian population
por: Kotarac, Nevena, et al.
Publicado: (2019)

lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells
por: Cao, Chen, et al.
Publicado: (2021)

Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma
por: Sanada, Hiroki, et al.
Publicado: (2019)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Value of M2BP in predicting in‐stent restenosis in patients after coronary drug‐eluting stent implantation
por: Yang, Le, et al.
Publicado: (2022)

miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
por: Gomes, Sofia E., et al.
Publicado: (2016)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Role of miR-143 and miR-146 in Risk Evaluation of Coronary Artery Diseases in Autopsied Samples
por: Tie, Jian, et al.
Publicado: (2023)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
por: Bolayırlı, Ibrahim Murat, et al.
Publicado: (2022)

Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome
por: Pilala, Katerina-Marina, et al.
Publicado: (2022)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation
por: Liang, Hengyi, et al.
Publicado: (2020)

Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

The Cluster of miR-143 and miR-145 Affects the Risk for Esophageal Squamous Cell Carcinoma through Co-Regulating Fascin Homolog 1
por: Liu, Ran, et al.
Publicado: (2012)

A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
por: Skjefstad, Kaja, et al.
Publicado: (2018)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
por: Johannessen, Charles, et al.
Publicado: (2017)

Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss
por: Xu, Rongyao, et al.
Publicado: (2021)

Study of miR-143 expression in stomach cancer
por: Huang, Shao-Jun, et al.
Publicado: (2018)

In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation
por: Kato, Yuta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6s2innmo0l86lh7t3p2tenrtal